Oxycodon Hcl Retard Teva (Oxycodone Hydrochloride)

Oxycodone Hydrochloride, the active ingredient in Oxycodon Hcl Retard Teva, is an opioid analgesic presented as a prolonged‑release oral tablet for oral use. It is indicated for the management of moderate to severe pain in adult patients when continuous, around‑the‑clock analgesia is required. GNH USA supplies Oxycodon Hcl Retard Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxycodon Hcl Retard Teva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxycodone Hydrochloride is an opioid analgesic that acts on the central nervous system to relieve pain.

- Chronic cancer‑related pain: provides sustained relief for patients with persistent tumor‑associated pain. - Post‑operative pain: maintains analgesia after major surgical procedures requiring continuous pain control. - Severe musculoskeletal pain: alleviates intense pain from conditions such as advanced osteoarthritis or spinal disorders. - Chronic non‑cancer pain: offers long‑acting relief for patients with severe, refractory pain not adequately managed by non‑opioid agents.

Adverse reactions may range from mild to severe and should be monitored throughout therapy.

Common Side Effects: - Constipation: reduced gastrointestinal motility leading to hard stools. - Nausea: sensation of queasiness often accompanied by an urge to vomit. - Drowsiness: increased sleepiness or reduced alertness. - Dry mouth: decreased salivary flow causing oral discomfort. - Lightheadedness: transient feeling of faintness, especially on standing. - Sweating: excessive perspiration unrelated to temperature or activity.

Serious or Rare Side Effects: - Respiratory depression: slowed or shallow breathing that can be life‑threatening. - Severe hypotension: marked drop in blood pressure causing dizziness or fainting. - Opioid dependence or addiction: compulsive use despite harmful consequences. - Seizures: rare occurrence of convulsive episodes. - Anaphylaxis: acute allergic reaction with airway compromise. - Adrenal insufficiency: impaired cortisol production leading to fatigue and weakness.

Before initiating therapy, clinicians should evaluate patient history and monitor for potential complications.

- Assess renal and hepatic function: adjust use if organ impairment is present. - Evaluate for respiratory disorders: avoid in patients with severe asthma or COPD. - Screen for substance‑use disorder: consider risk of dependence. - Use caution in the elderly: increased sensitivity to sedative effects. - Avoid concomitant CNS depressants: may potentiate sedation and respiratory depression. - Store below 25°C: keep in the original packaging, protect from moisture and direct sunlight.

Oxycodone Hydrochloride can interact with several drug classes, altering its efficacy or safety profile.

Major Interactions (Avoid): - Benzodiazepines: combined use can cause profound respiratory depression and excessive sedation. - Barbiturates: may intensify central nervous system depression and increase overdose risk. - Strong CYP3A4 inhibitors (e.g., ketoconazole, clarithromycin): raise oxycodone plasma levels, heightening toxicity.

Moderate Interactions (Monitor Closely): - CYP2D6 inhibitors (e.g., fluoxetine, paroxetine): modestly increase oxycodone concentrations. - Anticholinergic agents: may worsen constipation and urinary retention. - Antihistamines: can add to drowsiness and dizziness.